ACHL NASDAQ
Achilles Therapeutics plc
1W: +2.8%
1M: +7.2%
3M: +53.4%
1Y: +14.7%
3Y: -52.9%
$1.48
Last traded 2025-03-24 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$48M
+18.6% ▲
Capital Expenditures
$1M
+85.4% ▲
5Y CAGR: +432.1%
Free Cash Flow
-$50M
+26.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$42M
+55.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$14M | -$33M | -$61M | -$71M | -$70M |
| Depreciation & Amort. | $302K | $772K | $3M | $4M | $5M |
| Stock-Based Comp. | $719K | $3M | $6M | $7M | $6M |
| Change in Working Capital | -$1M | $3M | -$8M | -$6M | $10M |
| Other Non-Cash Items | -$9K | $1M | -$18K | $7M | $7K |
| Operating Cash Flow | -$14M | -$25M | -$59M | -$60M | -$48M |
| — Investing Activities — | |||||
| Capital Expenditures | -$942K | -$12M | -$8M | -$8M | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$8M | -$8M | $0 |
| Investing Cash Flow | -$942K | -$12M | -$8M | -$8M | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$388K | -$121K | $161M | $1 | $0 |
| Financing Cash Flow | $94M | $114M | $161K | $1K | $9K |
| Net Change in Cash | $87M | $80M | $89M | -$93M | -$42M |
| Cash End of Period | $98M | $178M | $266M | $173M | $132M |
| Free Cash Flow | -$15M | -$37M | -$67M | -$67M | -$50M |